| Product NDC: | 63739-062 |
| Proprietary Name: | Clonidine Hydrochloride |
| Non Proprietary Name: | Clonidine Hydrochloride |
| Active Ingredient(s): | .3 mg/1 & nbsp; Clonidine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63739-062 |
| Labeler Name: | McKesson Packaging Services Business Unit of McKesson Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA070976 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070905 |
| Package NDC: | 63739-062-10 |
| Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-062-10) > 10 TABLET in 1 BLISTER PACK |
| NDC Code | 63739-062-10 |
| Proprietary Name | Clonidine Hydrochloride |
| Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-062-10) > 10 TABLET in 1 BLISTER PACK |
| Product NDC | 63739-062 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clonidine Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20070905 |
| Marketing Category Name | ANDA |
| Labeler Name | McKesson Packaging Services Business Unit of McKesson Corporation |
| Substance Name | CLONIDINE HYDROCHLORIDE |
| Strength Number | .3 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |